Pharmabiz

UPES inaugurates World Congress on Health Sciences and Technology 2026

UPES inaugurates World Congress on Health Sciences and Technology 2026: Our Bureau, Mumbai Thursday, October 8, 2026, 14:30 Hrs [IST] UPES inaugurated the World Congress on Health ...
Pharmabiz

Nurix Therapeutics begins patient enrolment in phase 1b/2 combination study of bexobrutideg in chronic lymphocytic leukaemia

Nurix Therapeutics begins patient enrolment in phase 1b/2 combination study of bexobrutideg in chronic lymphocytic leukaemia: Brisbane, California Thursday, October 8, 2026, 18:00 ...
Pharmabiz

Nethradhama data shows 1 in 6 people over 40 with normal diagnosed with an undiagnosed eye condition

Nethradhama Super Speciality Eye Hospital found that approximately 1 in 6 had an underlying, previously undiagnosed eye condition. The conditions identified included early glaucoma, early diabetic ...
Pharmabiz

Boston Scientific appoints Joseph M. Fitzgerald as executive vice president and COO

Boston Scientific Corporation, a global medical technology leader, announced the appointment of Joseph M. Fitzgerald to ...
Pharmabiz

Tricog’s 7-state STEMI programme detects heart attacks in minutes, improves survival

Tricog’s 7-state STEMI programme detects heart attacks in minutes, improves survival: Our Bureau, Bengaluru Thursday, October 8, 2026, 17:15 Hrs [IST] Tricog’s Digital ECGs re ...
Pharmabiz

Digital CMC Consortium to focus on digitizing discovery and clinical trial workflows

Digital CMC Consortium to focus on digitizing discovery and clinical trial workflows: Dover, Delaware Thursday, October 8, 2026, 17:00 Hrs [IST] The Digital CMC Consortium has bee ...
Pharmabiz

Alcon launches Clareon PanOptix Pro in India, delivering the lowest light scatter of any trifocal IOL

Alcon launches Clareon PanOptix Pro in India, delivering the lowest light scatter of any trifocal IOL: Our Bureau, Bengaluru Thursday, October 8, 2026, 16:20 Hrs [IST] Alcon, the ...
Pharmabiz

Armata Pharma strengthens IP portfolio with two recent patent issuances in the US

Armata Pharma strengthens IP portfolio with two recent patent issuances in the US: Los Angeles Thursday, October 8, 2026, 16:00 Hrs [IST] Armata Pharmaceuticals, Inc., a late clin ...
Pharmabiz

Himalaya Wellness, CSIR-CDRI join forces to develop new therapy for PMOS, a major women’s health challenge

Himalaya Wellness, CSIR-CDRI join forces to develop new therapy for PMOS, a major women’s health challenge: Our Bureau, Bengaluru Thursday, October 8, 2026, 14:50 Hrs [IST] Hima ...
Pharmabiz

icotec receives Centers for Medicare & Medicaid Services approval for new technology add-on payment for its CMORE CT System

Centers for Medicare & Medicaid Services approval for new technology add-on payment for its CMORE CT System: Switzerland Thursday, October 8, 2026, 15:00 Hrs [IST] ...
Pharmabiz

MUVON Therapeutics announces positive 12-month phase 2 follow-up data confirming durable efficacy of its first-in-class muscle regeneration therapy in stress urinary incontinence

MUVON Therapeutics announces positive 12-month phase 2 follow-up data confirming durable efficacy of its first-in-class muscle regeneration therapy in stress urinary incontinence: ...
Pharmabiz

Motherhood Hospitals in collaboration with Fetal Medicine & Genetics Centre, hosts “Fetal Dialogues 2026”

Motherhood Hospitals, in collaboration with Fetal Medicine & Genetics Centre, hosted “Fetal Dialogues 2026” on October 3–4 at The Leela Ambience, Gurugram, a groundbreaking conference aimed at ...